Litcius/Paper detail

Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial

Michael Trauner, Cynthia Levy, Atsushi Tanaka, Zachary Goodman, Douglas Thorburn, Deepak Joshi, Kimmo Salminen, Kidist Yimam, Hiroyuki Isayama, Aldo J. Montaño‐Loza, Stephen H. Caldwell, Mark Danta, Martti Färkkilâ, Juan F. Gallegos‐Orozco, Stuart C. Gordon, Holger Hinrichsen, Pietro Invernizzi, Raj Vuppalanchi, Kaiyi Zhu, Jun Xu, Xiangyu Liu, Xiaomin Lu, Gerald Crans, Shahla Bolbolan, Lisa Boyette, Muhsen Al-ani, William Barchuk, Timothy R. Watkins, Mark C. Genovese, Christopher L. Bowlus

2025˜The œLancet. Gastroenterology & hepatology9 citationsDOI

Topics & Concepts

MedicineInternal medicinePrimary sclerosing cholangitisPhase (matter)GastroenterologySurgeryClinical trialBiliary tractUrsodeoxycholic acidPrimary (astronomy)Liver Diseases and ImmunityGallbladder and Bile Duct DisordersPediatric Hepatobiliary Diseases and Treatments